<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-10-21</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39428984/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Beyond buzzwords: fostering interdisciplinary and collaborative global health research in Germany and beyond</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39428984-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Despite achievements, challenges persist. Wider support, especially from universities and research institutions, is necessary to make global health research an attractive career path and to reduce bureaucratic barriers for collaborators in LMICs. Sustained, longer-term federal funding mechanisms will also be essential for ongoing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39429031/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20241021184233&amp;v=2.18.0.post9&#43;e462414">High-Accuracy and Lightweight Image Classification Network for Optimizing Lymphoblastic Leukemia Diagnosisy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39429031-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20241021184233-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Leukemia is a hematological malignancy that significantly impacts the human immune system. Early detection helps to effectively manage and treat cancer. Although deep learning techniques hold promise for early detection of blood disorders, their effectiveness is often limited by the physical constraints of available datasets and deployed devices. For this investigation, we collect an excellent-quality dataset of 17,826 morphological bone marrow cell images from 85 patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39429856/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Deep Mouse Brain Two-Photon Near-Infrared Fluorescence Imaging Using a Superconducting Nanowire Single-Photon Detector Array</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39429856-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Two-photon microscopy (2PM) has become an important tool in biology to study the structure and function of intact tissues in vivo. However, adult mammalian tissues such as the mouse brain are highly scattering, thereby putting fundamental limits on the achievable imaging depth, which typically reside at around 600-800 Î¼m. In principle, shifting both the excitation as well as (fluorescence) emission light to the shortwave near-infrared (SWIR, 1000-1700 nm) region promises substantially &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39430093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Prevalence of bacterial vaginosis, sexually transmitted infections and their association with HPV infections in asymptomatic women attending antenatal care in Ethiopia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39430093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Sexually transmitted infections (STIs) and human papillomavirus (HPV) infections are common among women of reproductive age and can lead to infertility, adverse pregnancy outcomes, neonatal infections and cervical cancer. In countries with limited medical coverage, untreated infections contribute to high morbidity. This study aimed to expand the current knowledge on the prevalence of bacterial vaginosis (BV) and STIs in pregnant Ethiopian women and assess the association of these conditions &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39430394/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Astrocytomas of the spinal cord</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39430394-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Tumors of astrocytic origin represent one of the most frequent entities among the overall rare group of spinal cord gliomas. Initial clinical symptoms are often unspecific, and sensorimotor signs localizing to the spinal cord occur with progressing tumor growth. On MRI, a hyperintense intrinsic spinal cord signal on T(2)-weighted sequences with varying degrees of contrast enhancement raises suspicion for an infiltrative neoplasm. Blood and CSF analysis serves to exclude an infectious &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39430902/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Towards international collaboration of clinical research networks for EMDR: the EMDR Pain Network Germany</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39430902-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based treatment, primarily established for post-traumatic stress disorder (PTSD). While it is increasingly being applied to chronic pain, its efficacy in this area is not yet supported by the same level of evidence as that which exists for PTSD. Studies in this area often show heterogeneous results with small case numbers, and the potential side effects of EMDR in the treatment of chronic pain are not &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431327/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Endovascular therapy versus medical management in isolated posterior cerebral artery acute ischemic stroke: A multinational multicenter propensity score-weighted study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431327-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: EVT for iPCAo is associated with better neurological outcomes and lower mortality compared to MM, without an increased risk of hemorrhagic complications. Nevertheless, these results should be interpreted with caution due to the study&rsquo;s observational design. The findings are hypothesis-generating and highlight the need for future randomized controlled trials to confirm these observations and establish definitive treatment guidelines for this patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431354/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: a meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431354-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: NBS is a prerequisite to improved outcome in individuals with MSUD; however, health benefit critically depends on the quality of the national healthcare &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431591/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation initiation compared to a single-day admission model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431591-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objective: Noninvasive ventilation (NIV) is the primary treatment for respiratory insufficiency in neuromuscular disease. NIV implementation is usually conducted within hospitals; however, in-home implementation with intensive follow-up is an effective alternative. This pilot study aimed to assess model feasibility, acceptability, and NIV usage at 12-weeks after a single visit in-home implementation of NIV with remote monitoring follow-up (NIV@Home) compared to an in-hospital day admission &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431717/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241021184312&amp;v=2.18.0.post9&#43;e462414">Navigating Clinicians&#39; Conscience-Based Refusals to Provide Lawful Medical Care</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431717-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241021184312-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431725/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241021184312&amp;v=2.18.0.post9&#43;e462414">Taking Our Own Medicine</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431725-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241021184312-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431739/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241021184312&amp;v=2.18.0.post9&#43;e462414">Glycogenic Hepatopathy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431739-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241021184312-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39431740/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241021184312&amp;v=2.18.0.post9&#43;e462414">The Opportunity Costs of Medicare Advantage Plan Rebates</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39431740-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241021184312-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432026/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432026-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: These findings underscore the severe prognostic impact of CDKN2A/B deletion in IDH-mutant astrocytomas and highlight the need for further refinement of tumor prognostic categorization. Our results provide a key benchmark of baseline patient outcomes for therapeutic trials, underscoring the importance of CDKN2A/B status assessment, in addition to histologic grading, in clinical trial design and therapeutic decision-making for IDH-mutant astrocytoma &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432031/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Preoperative nTMS analysis: a sensitive tool to detect imminent motor deficits in brain tumor patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432031-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The current results suggest that the RC ratio, CSP ratio and RMT ratio individually are sensitive markers associated with the motor outcome 7 days and 3 months after tumor resection in a presumed motor eloquent location. They can therefore supply valuable information during preoperative risk-benefit-balancing. However, underlying neurophysiological mechanisms might be too similar to make the parameters meaningful in a combined &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432252/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432252-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cardiogenic shock (CS) is a devastating and fatal complication of acute myocardial infarction (AMI). CS can affect the pharmacokinetics and pharmacodynamics of medications. The unique properties of cangrelor make it the optimal P2Y12 inhibitor for CS-AMI, in terms of both efficacy and safety. The DAPT-SHOCK-AMI trial (ClinicalTrials.gov: NCT03551964; EudraCT: 2018-002161-19) will assess the benefits of cangrelor in patients with an initial CS-AMI undergoing primary angioplasty. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432536/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">LD-transpeptidation is crucial for fitness and polar growth in Agrobacterium tumefaciens</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432536-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Peptidoglycan (PG), a mesh-like structure which is the primary component of the bacterial cell wall, is crucial to maintain cell integrity and shape. While most bacteria rely on penicillin binding proteins (PBPs) for crosslinking, some species also employ LD-transpeptidases (LDTs). Unlike PBPs, the essentiality and biological functions of LDTs remain largely unclear. The Hyphomicrobiales order of the Alphaproteobacteria, known for their polar growth, have PG which is unusually rich &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432804/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Harmonizing neuropathic pain research: outcomes of the London consensus meeting on peripheral tissue studies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432804-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Neuropathic pain remains difficult to treat, with drug development hampered by an incomplete understanding of the pathogenesis of the condition, as well as a lack of biomarkers. The problem is compounded by the scarcity of relevant human peripheral tissues, including skin, nerves, and dorsal root ganglia. Efforts to obtain such samples are accelerating, increasing the need for standardisation across laboratories. In this white paper, we report on a consensus meeting attended by neuropathic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39432810/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Peripheral or central origin of chronic pain? Mu!</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39432810-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCxXYziOM">å»çåï¼çåå¸é®ææç¥¨çäºæãä»é®æè¯¥ä¸è¯¥æç¥¨ï¼æè¯´ä½ ä»¬çååºé¨å£äº¤éå¾å·®ï¼å ä¸ºé¿æä¿®è·¯ä½æ¯å´ä¸ç´ä¿®ä¸å¥½ï¼æä»¥æ»æè·¯éï¼ä¸¥éå½±åäº¤éï¼å¯¼è´è®¸å¤äººä¸æ¿æ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ocxxyziom/">
    
    
    
    
    
      
    
    å»çåï¼çåå¸é®ææç¥¨çäºæãä»é®æè¯¥ä¸è¯¥æç¥¨ï¼æè¯´ä½ ä»¬çååºé¨å£äº¤éå¾å·®ï¼å ä¸ºé¿æä¿®è·¯ä½æ¯å´ä¸ç´ä¿®ä¸å¥½ï¼æä»¥æ»æè·¯éï¼ä¸¥éå½±åäº¤éï¼å¯¼è´è®¸å¤äººä¸æ¿æå°è¿éæ¥çåï¼è¿å°±æ¯city councilçé®é¢ï¼æä»¥å½ç¶åºè¯¥æç¥¨ï¼è¶æ¯down ballotï¼å°æ¹éä¸¾æç¥¨ï¼è¶éè¦ï¼è¿ç´æ¥å³å®äºä½ åºé¨å£çäº¤éåäººæµãå¦å¤ï¼é£äºpropï¼proposition/å¨å·å¬æç«æ³è®®æ¡ï¼ï¼æ¯å¦è¯¥ä¸è¯¥å»ºè¾éæä¸­å¿ï¼è¿äºè·æ®éäººçæ´»æ¯æ¯ç¸å³ã<!-- raw HTML omitted --><!-- raw HTML omitted -->ç¶èä»é®åºè¯¥ç¨åªç§æ¹å¼æãä½ä¸ºpoll workerï¼å¹¶ä¸å°å¨å¤§éç»§ç»­å½poll workerï¼ï¼æç»ä»è§£éäºæç¥¨æ¹å¼ï¼é®å¯æç¥¨åç°åºæç¥¨ãæè¯´å å·å±æ°ä¸è¬é½é®å¯éç¥¨ï¼æ¯å¼ éç¥¨é½å¯ä»¥è¿½è¸ªï¼éå¸¸ä¾¿å©ãèä¹æä»¥é¦éé®å¯æ¯å ä¸ºå å·éç¥¨æé¿ï¼é¤äºé¿é¿çdown ballotï¼èä¸å å·è¿æå¤§épropãå å·æ¯ç¾å½ææ°ä¸»çå·ä¹ä¸ï¼å¤§éå·ç«æ³é½ä¸æ¯å·è®®ä¼å³å®ç &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCzDpmBZR">GWUçBosqueç»å¨PLOS Pathogensä¸åè¡¨äºä¸é¡¹HIVæ²»æè¯ç©å¼åè®ºæï¼æ¥éäºFDAå·²ç»æ¹åä¸å¸çè¯ç©Isotretinoinï¼å¼ç»´ç²é¸ï¼å¨HIVæ²»æä¸­çæ½å¨ä½ç¨ã2017å¹´ï¼è¯¥ç»æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oczdpmbzr/">
    
    
    
    
    
      
    
    GWUçBosqueç»å¨PLOS Pathogensä¸åè¡¨äºä¸é¡¹HIVæ²»æè¯ç©å¼åè®ºæï¼æ¥éäºFDAå·²ç»æ¹åä¸å¸çè¯ç©Isotretinoinï¼å¼ç»´ç²é¸ï¼å¨HIVæ²»æä¸­çæ½å¨ä½ç¨ã<!-- raw HTML omitted --><!-- raw HTML omitted -->2017å¹´ï¼è¯¥ç»æ¥éäºå¼åçHIVæ½å¨å°åå­æ²»æè¯ç©HODHBtï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½é¡µé¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼ï¼å®éè¿STATä¾èµæ§éå¾æ¿æ´»å &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBD1uYrr">ç½èÂ·å¢æ£®å ¡è¯´ï¼âå¨åå¯¹âç·æ§ç¹æâçæäºä¸­è¡¨ç°å¾åæ¯ç®ä¸æ ·çèµäº§é¶çº§å¥³æ§ï¼è¯å®ä¼æ¯å¥¹ä»¬é¶çº§ä¸­çç·æ§åå¨å¾å¤ãæäº§é¶çº§çå¥³æ§æ»æ¯çç­å°æå«å¯¹å³å¨äººæ°ç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbd1uyrr/">
    
    
    
    
    
      
    
    ç½èÂ·å¢æ£®å ¡è¯´ï¼âå¨åå¯¹âç·æ§ç¹æâçæäºä¸­è¡¨ç°å¾åæ¯ç®ä¸æ ·çèµäº§é¶çº§å¥³æ§ï¼è¯å®ä¼æ¯å¥¹ä»¬é¶çº§ä¸­çç·æ§åå¨å¾å¤ãæäº§é¶çº§çå¥³æ§æ»æ¯çç­å°æå«å¯¹å³å¨äººæ°çå¥ååå¥´å½¹ï¼å¥¹ä»¬éè¿å¥ååå¥´å½¹é´æ¥å°è·å¾äºå¥¹ä»¬å¨ç¤¾ä¼ä¸æ ç¨ççå­çææ®µãâ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»è¿å¥è¯ççè®©äººåä¸äºã<!-- raw HTML omitted -->ð»æ¯ä¸ªå³å¨èé½åºè¯¥åä¸äºã<!-- raw HTML omitted -->ð»è¿ç§å¯¹å³å¨èçç¾è¾±è¿çäºä»ä¹âåå¾âãâæ®ä¿¡âã <!-- raw HTML omitted -->ð»ç»´æ¤å¥³æ§æçï¼é çæ¯æ¶é¤æ­§è§ãåæ³ä¿éæçãè¿½æ±å¹³ç­ãç§¯æåä¸åé¡¹ç¤¾ä¼äºå¡ãåååæ¥å¦å¥³å¨ç¤¾ä¼ä¸»ä¹ç°ä»£åå»ºè®¾ä¸­çä½ç¨ã<!-- raw HTML omitted -->ð»ä»¥åæéè¦çï¼ç§¯æåä¸ç¤¾ä¼å³å¨ã<!-- raw HTML omitted -->ð»çè³è¿æ³¢ä¼å¨ä¹è¯´ï¼âï¼å©å§» &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBih2ocF">ð»ä¸ºä»ä¹æ»æäººè§å¾èªå·±æä¸æ®µå¤±è´¥çè²å¿ç»åæ¯å¯¹çï¼è¿è¦åä¸ç½åäº«ã [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbih2ocf/">
    
    
    
    
    
      
    
    ð»ä¸ºä»ä¹æ»æäººè§å¾èªå·±æä¸æ®µå¤±è´¥çè²å¿ç»åæ¯å¯¹çï¼è¿è¦åä¸ç½åäº«ã <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBlfEPDj">ð»ä»¥è²åå¸æ³é¨ç§°ï¼7 åä»¥è²åäººå âæ¶å«ä¸ºä¼ææ§è¡é´è°ä»»å¡âèè¢«æï¼å¶ä¸­åæ¬ææç§çåæ¶éä»¥è²ååéåºå°çä¿¡æ¯ãð»ä»¥è²åç§°ï¼âä»ä»¬æç§ä¼ææä½äººåç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocblfepdj/">
    
    
    
    
    
      
    
    ð»ä»¥è²åå¸æ³é¨ç§°ï¼7 åä»¥è²åäººå âæ¶å«ä¸ºä¼ææ§è¡é´è°ä»»å¡âèè¢«æï¼å¶ä¸­åæ¬ææç§çåæ¶éä»¥è²ååéåºå°çä¿¡æ¯ã<!-- raw HTML omitted -->ð»ä»¥è²åç§°ï¼âä»ä»¬æç§ä¼ææä½äººåçæç¤ºï¼æ¶éäºæå³åç¦æå§åæé©¬ç¹å¤§å«ç©ºååºå°ãç¹æç»´å¤«ä»¥è²åéåæ»é¨ãéç©¹ãææå°¼è®­ç»åºå°åå¶ä»å°ç¹çææ¥ãâ<!-- raw HTML omitted -->ð»è¿ä¸äººæ¥èªæµ·æ³ååé¨å¶ä»åéï¼å¶ä¸­åæ¬ä¸åéåµåä¸¤åæªæå¹´äººã<!-- raw HTML omitted -->ð»æ 7 ä¸ªï¼ç©éæ¯å§ï¼<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23&amp;amp;extparam=%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23&amp;amp;extparam=%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBmccC5H">ð»ä¹åå°åªä½ï¼å°æ©æé£è¶èæ¢å°åºãð»ä¸æ­¤åæ¶ï¼ç¾å½å½é²é¨é¿å³åå¾·-å¥¥æ¯æ±æ­£å¨åºè¾è®¿é®ãð»via vk [å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbmccc5h/">
    
    
    
    
    
      
    
    ð»ä¹åå°åªä½ï¼å°æ©æé£è¶èæ¢å°åºã<!-- raw HTML omitted -->ð»ä¸æ­¤åæ¶ï¼ç¾å½å½é²é¨é¿å³åå¾·-å¥¥æ¯æ±æ­£å¨åºè¾è®¿é®ã<!-- raw HTML omitted -->ð»via vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaimg.cn/orj480/639b1bfbly1huu9b4nvy5j20j40zkdgg.jpg%22">https://tvax4.sinaimg.cn/orj480/639b1bfbly1huu9b4nvy5j20j40zkdgg.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBqAlq3H">ð»âä½ æ¯ä¸æ¯ç©ä¸èµ·ï¼â åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbqalq3h/">
    
    
    
    
    
      
    
    ð»âä½ æ¯ä¸æ¯ç©ä¸èµ·ï¼â <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/quVVLDKBlx08iY76SBzO01041200nYG20E010.mp4?la">https://f.video.weibocdn.com/o0/quVVLDKBlx08iY76SBzO01041200nYG20E010.mp4?la</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBTSmEgn">ð»ä»¥è²åå¹¿æ­å¬å¸ Kan æ°é»å°ä»¥åé©±èµ¶å æ²äººç¦»å¼è´¾å·´å©äºé¾æ°è¥çæ­» äº¡ è¡ åï¼ä½ä¸ºâä»¥è²åèå©âçç»æç»é¢æ­æ¾åºæ¥ãð»Kan æ°é»è¯´ï¼â××¢×××ª: ×¢××...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbtsmegn/">
    
    
    
    
    
      
    
    ð»ä»¥è²åå¹¿æ­å¬å¸ Kan æ°é»å°ä»¥åé©±èµ¶å æ²äººç¦»å¼è´¾å·´å©äºé¾æ°è¥çæ­» äº¡ è¡ åï¼ä½ä¸ºâä»¥è²åèå©âçç»æç»é¢æ­æ¾åºæ¥ã<!-- raw HTML omitted -->ð»Kan æ°é»è¯´ï¼â××¢×××ª: ×¢×××ª ×¢××××× ××ª ×&rsquo;×××××ï¼å æ²äººç¦»å¼è´¾å·´å©äºï¼â<!-- raw HTML omitted -->ð»ä»¥åè¿æ¾ç«çç§äºè´¾å·´å©äºçå°åº¦å°¼è¥¿äºå»é¢ï¼å¾7ï¼ã<!-- raw HTML omitted -->ð»å°±åå¾8-9ä¸æ ·ï¼åå²ä¸ä»å¨ä¸æ­éæ¼ï¼çè³æ¼éµã<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23&amp;amp;extparam=%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23&amp;amp;extparam=%23%E8%BF%99%E4%B8%80%E6%AC%A1%E6%83%85%E6%8A%A5%E5%A4%96%E6%B3%84%E8%AE%A9%E4%BB%A5%E8%89%B2%E5%88%97%E6%9B%B4%E5%B0%B4%E5%B0%AC%E4%BA%86%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCBv6pEyk">ð»è¿å¤§houseï¼äº¤æ¿è´¨éä¹ä¸åçåã åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocbv6peyk/">
    
    
    
    
    
      
    
    ð»è¿å¤§houseï¼äº¤æ¿è´¨éä¹ä¸åçåã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/DxlV6jC6lx08iY7SiaDC01041200Mdky0E">https://f.video.weibocdn.com/o0/DxlV6jC6lx08iY7SiaDC01041200Mdky0E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCEpKk2U2">ð»æéè¾ä¸åå¨#ç¹ææ®è·å°éº¦å½å³æå·¥# [å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocepkk2u2/">
    
    
    
    
    
      
    
    ð»æéè¾ä¸åå¨<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç¹ææ®è·å°éº¦å½å³æå·¥#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbgy1huumt61rjrj20tk0tkjub.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbgy1huumt61rjrj20tk0tkjub.jpg&quot;</a> referrerpolicy=&ldquo;no-re &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCEuA8Wru">ð»ä¿åªï¼ä¿åä¸æ¯é¨éå¨æ¥åºéè¯ºæ¹åå é¢ä¸å¤ä¹åç¿æ¸£å éµå°åï¼åæ¶åèµ·äºð·ðºåð°ðµå½æãð»ä¼ç©ã#å¤äº¤é¨ååºæåå·²è¿å¥ä¹åå°æåº# [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oceua8wru/">
    
    
    
    
    
      
    
    ð»ä¿åªï¼ä¿åä¸æ¯é¨éå¨æ¥åºéè¯ºæ¹åå é¢ä¸å¤ä¹åç¿æ¸£å éµå°åï¼åæ¶åèµ·äºð·ðºåð°ðµå½æã<!-- raw HTML omitted -->ð»ä¼ç©ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å¤äº¤é¨ååºæåå·²è¿å¥ä¹åå°æåº#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/63">https://tvax1.sinaimg.cn/large/63</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OCEvNsIlX">ï¼På°¼çå¢ã//@å¤¸å¤¸å°ç²¾çµ:è¿å¾På¾æå¿«ç¬æ­»ï¼ç¹ææ®å¨éº¦å½å³æå·¥ï¼è¿ç®ç´æ¯è³å¿çºµç«ç¯åï¼ð¥ð è¯åï¼88åï¼åææ»¡åï¼ - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;ð»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ocevnsilx/">
    
    
    
    
    
      
    
    ï¼På°¼çå¢ã//<!-- raw HTML omitted -->@å¤¸å¤¸å°ç²¾çµ<!-- raw HTML omitted -->:è¿å¾På¾æå¿«ç¬æ­»ï¼ç¹ææ®å¨éº¦å½å³æå·¥ï¼è¿ç®ç´æ¯è³å¿çºµç«ç¯åï¼ð¥ð è¯åï¼88åï¼åææ»¡åï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»æéè¾ä¸åå¨<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCxDwuclk">åäº«å¾ç [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocxdwuclk/">
    
    
    
    
    
      
    
    åäº«å¾ç <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCydeelZN">è½ç¼å¾®å - è½¬å @é¡¶ç­TENä½¿:&amp;ensp;ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.10.21 11:40ãååã&lt;å¾&gt;åæµ·é¿é¿å© [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocydeelzn/">
    
    
    
    
    
      
    
    è½ç¼å¾®å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@é¡¶ç­TENä½¿<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCDkvDyCk">ä¹ä¿å²ç»ªé#shiorigram# ä»æä¹æ¯ï¼ï¼æä¸10:45ï½ï¼JSTï¼è¢«æªæ¥çææ´å»ï¼ï¼æ´å»ä»å¤©å¼å§è¿å¥ç¬¬ä¸å¨ï¼ï¼åçäºæ°çé®é¢...ä¼åæä»ä¹èµ°åå¢...ï¼æ¬å¨ä¹æ¬è¯·æå¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocdkvdyck/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shio &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCEd6FbOs">ä¹ä¿å²ç»ªé ãè¢«æªæ¥çææ´å»ï¼ãEP.9 é¡¶ç­TENä½¿çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oced6fbos/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ãè¢«æªæ¥çææ´å»ï¼ãEP.9 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09">https://h5.sinaimg.cn/upload/2015/09</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCy77cVFx">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.10.21 11:40ãååã&lt;å¾&gt;åæµ·é¿é¿å© [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocy77cvfx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCy7dBfM8">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.10.21 11:40ãåååãæ©åä»å¤©ä¹å æ²¹å§è¶åæ¬¢æ©ä¸èµ·æ¥ä¼¸ã¼ã¼ã¼æè°çæ¶é´ãæ©ä¸èµ·æ¥èå­é¥¿çæ¶åå°±å¾å¹¸ç¦ãå¥½åï¼ï¼åç¹ä»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-21</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocy7dbfm8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427343/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241021184313&amp;v=2.18.0.post9&#43;e462414">The high-grade B-cell lymphomas: Double hit and more</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427343-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241021184313-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Both the 2022 WHO HAEM5 and the International Consensus Classification of lymphoma have refined the way we now approach high-grade B-cell lymphoma (HGBL) with MYC and BCL2 and/or BCL6 rearrangements moving the previous generation of classification a step forward. The unifying biology of MYC/BCL2 tumours has been clearer and their inferior prognosis confirmed compared to those with morphological similarities but lacking the classifying cytogenetic abnormalities. FISH testing has largely &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Radio-sulphur as groundwater residence time tracer - Adapting the &lt;sup&gt;35&lt;/sup&gt;S extraction approach for water samples rich in sulphate</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cosmogenic radio-sulphur (^(35)S) is applicable as aqueous environmental tracer for investigating sub-yearly groundwater residence times. For the purpose ^(35)SO(4) has to be extracted from large-volume water samples (ca. 20 l) and measured by liquid scintillation counting (LSC). Publications that discuss sample preparation approaches focus on waters with low or moderate sulphate concentrations based on sulphate extraction using an ion-exchange resin. However, sulphate extraction by &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427572/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Impact of mild hypercapnia in critically ill patients with metabolic acidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427572-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In patients with metabolic acidosis, after adjustment for potential confounders, mild hypercapnia does not increase the MAKE-30 rate and does not have a major impact on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427704/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Addressing the Rise of Autochthonous Vector-Borne Diseases in a Warming Europe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427704-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors - Identification of high-risk patients and risk mitigation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The risk of variable-RBE-induced NTCP strongly depends on patient-specific factors and the considered side-effect. A small distance between the tumor and OARs notably increases the risk. Integrating biologically-guided objectives into treatment planning can effectively mitigate the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39427977/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Sarcopenia influences clinical outcome in hospitalized patients with peripheral artery disease aged 75 years and older</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39427977-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Sarcopenia is an under-recognized condition in PAD patients of high clinical relevance causing a crucial disease burden. Awareness of the ailment needs to be increased in daily clinical practice to identify sarcopenia and improve clinical outcome of this vulnerable patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39428453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241021184321&amp;v=2.18.0.post9&#43;e462414">Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39428453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241021184321-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The 9-item HEIS is the first CHE-specific PRO measure developed and validated according to regulatory guidance for assessment of the impact of CHE on key domains of HRQoL. This article provides evidence of strong content and psychometric validity and shows improvements of â¥ 1.3 points in HEIS score and HEIS PDAL score, and improvements of â¥ 1.5 points in HEIS Emb score represent clinically meaningful, important &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCoj8tAH7">Big Surå¨å¤§é£ä¸­ï¼èè¿ä¸ªæµ·æ»©æ¯è²éå¸¸å¥ç¹ã ç¾å½Â·å¤§çå° å­éµå¨å¬æ­çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ocoj8tah7/">
    
    
    
    
    
      
    
    Big Surå¨å¤§é£ä¸­ï¼èè¿ä¸ªæµ·æ»©æ¯è²éå¸¸å¥ç¹ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å½Â·å¤§çå°<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCqyw8xgr">NIH LIR Chunç»å¨JCIåè¡¨äºçç®ç­HIVæ²»æç ç©¶ï¼Letterï¼ï¼æ¥éäºå¨HIVæææ¥æ§æå¼å§æè¯ï¼ARTï¼çHIVææèï¼å¶å¤å¶å¨è½åHIV DNAï¼Intact HIV DNA - IPDï¼æ¾è...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ocqyw8xgr/">
    
    
    
    
    
      
    
    NIH LIR Chunç»å¨JCIåè¡¨äºçç®ç­HIVæ²»æç ç©¶ï¼Letterï¼ï¼æ¥éäºå¨HIVæææ¥æ§æå¼å§æè¯ï¼ARTï¼çHIVææèï¼å¶å¤å¶å¨è½åHIV DNAï¼Intact HIV DNA - IPDï¼æ¾èä½äºå¨æ¢æ§æå¼å§æè¯çææèãèIPDæ¯å³å®HIVæ£èå¨è¯éªæ§åè¯ï¼ATIï¼åHIVåå¼¹æ¶é´åç¨åº¦æå³é®çHIV DNAãHIVæææ¥æ§æå¼å§æè¯çHIVææèçç¼ºé·åHIV DNAä¹ä½äºæ¢æ§æææèãèå¨ATIæ¶æï¼è¿ç§å¨èåºHIV DNAçå·®å¼æ´å ææ¾ãè¿é æäºé¢æçATIæ¶æåå¼¹HIV RNAå·®å¼ãåæ¶ï¼æ¥æ§ææè¯æ£èMAITç»èåCD56dim NKç»èä¹æ¾èé«äºæ¢æ§ææ£èãè¿ä¸ç»æç¡®è®¤äºæ¥æ§æï¼æ©æï¼æè¯æ£èHIV DNAæ´å°ï¼åç«ç»èåå¸é¢çæ´é«ï¼å æ­¤æ´æå¯è½å®ç°HIVæ²»æã&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/4a994b1dgy1husxlw48wwj23ji4dfkjo.jpg%22">https://tvax1.sinaimg.cn/large/4a994b1dgy1husxlw48wwj23ji4dfkjo.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OCwFDetds">ä¸åä»Marinaä¸ç´èµ°å°Presidioï¼è¿ä¸ªè·¯å¾ãå°å½¢åè·ç¦»å¾åè¿å»å¨DCä»Georgetownå°æè¯çºªå¿µå ãä»å¤©å¤©ç©ºæ´æï¼70åº¦ï¼ç¹å«éåæ¢è·ãä»Lyon Stä¸ç´èµ°å°Crissy Fiel...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ocwfdetds/">
    
    
    
    
    
      
    
    ä¸åä»Marinaä¸ç´èµ°å°Presidioï¼è¿ä¸ªè·¯å¾ãå°å½¢åè·ç¦»å¾åè¿å»å¨DCä»Georgetownå°æè¯çºªå¿µå ãä»å¤©å¤©ç©ºæ´æï¼70åº¦ï¼ç¹å«éåæ¢è·ãä»Lyon Stä¸ç´èµ°å°Crissy Fieldï¼åèµ°åæ¥ï¼3.2 miles 5.2å¬éãSFåå¸ï¼å°¤å¶æ¯å¤ªå¹³æ´è¾¹ï¼æ¯1906å¹´å¤§å°éåéå»ºçï¼èå¥äºå¾å¤åå¸è®¾è®¡ç°ä»£ç¾å­¦ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å½Â·Palace of Fine Arts<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/4a994b1dgy1hutnxp4lqej24eo3b0b2j.jpg%22">https://tvax1.sinaimg.cn/large/4a994b1dgy1hutnxp4lqej24eo3b0b2j.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCom5wZei">è½ç¼å¾®å - è½¬å @suzukazejun:&amp;ensp;10æ20æ¥(æ¥)ãã11:25æ¾éMBS/TBSç³» æç±å¤§é¸ï¼ä¿³åªã»æ­æ çç°çµµæ¢¨è± ï¼¼æ¾éã«åé§ãã¦...ååºãç¹å¥æ åãã®â ãå¬éâ¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocom5wzei/">
    
    
    
    
    
      
    
    è½ç¼å¾®å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@suzukazejun<!-- raw HTML omitted -->:â10æ20æ¥(æ¥)ãã11:25æ¾é<!-- raw HTML omitted -->MBS/TBSç³» æç±å¤§é¸<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼<!-- raw HTML omitted -->ä¿³åªã»æ­æ çç°çµµæ¢¨è±<!-- raw HTML omitted --> ï¼¼<!-- raw HTML omitted --><!-- raw HTML omitted -->æ¾éã«åé§ãã¦&hellip;<!-- raw HTML omitted -->ååºãç¹å¥æ åãã®â ãå¬éâ¼<!-- raw HTML omitted --><!-- raw HTML omitted -->ãéèªã®æ®å½±ç¾å ´ãç·¨<!-- raw HTML omitted --><!-- raw HTML omitted -->ikuta_staff<!-- raw HTML omitted --> ããã¡ãã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->suzukazejunçå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCoot94o7">è½ç¼å¾®å - è½¬å @AyaTea:&amp;ensp;åç°ç»«ä¹#åç°ç»«ä¹ã¯ãªã¹ãã£ã¼##åç°ç»«ä¹åèä¸è# ãIns Storyã 241019 Part2èå°å§æ°´æç¯®å­ä»å¤©ä¹æ¯éå¸¸æè°¢ï¼æ¾è½»æ¾å¥½å¥½å°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocoot94o7/">
    
    
    
    
    
      
    
    è½ç¼å¾®å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@AyaTea<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åç°ç»«ä¹<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%90%89%E7%94%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%90%89%E7%94%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCqiMgKBf">è½ç¼å¾®å - è½¬å @é´æ¨çµ¢é³å­å¹çµ:&amp;ensp;éæ¨ç»é³#é´æ¨çµ¢é³#10.19insãé´æ¨çµ¢é³ç²ä¸ä¿±ä¹é¨1å¨å¹´æ´»å¨ï½è¿å»ä¸æªæ¥ï½ãæè°¢åæ¥ä¼åºçåä½ï¼æè°¢éè¿ç´æ­è§ççå...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocqimgkbf/">
    
    
    
    
    
      
    
    è½ç¼å¾®å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@é´æ¨çµ¢é³å­å¹çµ<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->éæ¨ç»é³<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCqkHB4yJ">åäº«å¾ç [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocqkhb4yj/">
    
    
    
    
    
      
    
    åäº«å¾ç <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OCubPdXSM">ç¾å¨ç¼é¡å¨æ¯çé[åå] [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ocubpdxsm/">
    
    
    
    
    
      
    
    ç¾å¨ç¼é¡å¨æ¯çé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCqM8aGwE">ä¹ä¿å²ç»ªé ä¹æ¨ææä¸çè¿å¼ ç§çè½ä¼ è¾¾åºä¸èµ·èµ°è¿æ¼«é¿å²æçåå¿æ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocqm8agwe/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¹æ¨æ<!-- raw HTML omitted -->æä¸çè¿å¼ ç§çè½ä¼ è¾¾åºä¸èµ·èµ°è¿æ¼«é¿å²æçåå¿æ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCqxb12WL">ä¹ä¿å²ç»ªé#shiorigram# GirlsAwardæè°¢å¤§å®¶ð¦ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocqxb12wl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCrN7tsC2">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.10.20 18:27ãè¯¶å¿å¿ãä¸ºä»ä¹èå­é¥¿çæ¶åå»è¶å¸å°±ä¼å¿ä¸ä½åç§ä¹°ä¹°ä¹°å¢ãå¥æªãè¯´èµ·æ¥èå­ä¸é¥¿çæ¶åå»è¶å¸ä¸ºä»ä¹ä¹å¿ä¸ä½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocrn7tsc2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCrULa2Mz">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.10.20 19:35ãåååãææ³ï¼ä¸ç®¡ä»ä¹æ¶åï¼äººé½è¦çæèªå·±ãåæ¬¢èªå·±åæ¬¢çä¸è¥¿ä¹æ²¡ä»ä¹ä¸å¥½ãæç°å¨è§å¾å§ï¼å¦æå ä¸ºå«äºº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocrula2mz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCrXXvUk1">ä¹ä¿å²ç»ªé#shiorigram# .å¥è·çéåº¦æ¯å¤©é½ä¼åï¼æä»¥è¦æ³¨æå«è®©èªå·±æéãå»è¿½éï¼å»ç­å¾ãå°å¤´æ¥é¾åä¹ä¹ä¼«ç«ï¼ä¸ç¥é½å»äºåªéãè¿è¿æ ·çæ¥å­ä¹ä¸ç¦è®©ææå°æ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocrxxvuk1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OCu3FkXJM">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªé# æ´æ°äºç¿»è¯ - è½¬å @é¡¶ç­TENä½¿:&amp;ensp;ä¹ä¿å²ç»ªé ãTVLIFEã No.21åéåæ¥ï¼ç´å»å¨å¹¿æ­ãä¹æ¨å46çAll Night Nipponãä¸­æä»»ç¬¬äºä»£ä¸»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ocu3fkxjm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?con">https://m.weibo.cn/search?con</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/cn/2024/10/20/vegetarian/">ç´ é£ä¼¦ç</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-20</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-cn-2024-10-20-vegetarian/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

